60 ingredients subject to bioequivalence testing within this month

The Korea Food and Drug Administration (KFDA) said it will notify a total of 60 ingredients (2,698 products) that will be subject to bioequivalence testing within this month.

Among the ingredients to be included in the mandatory list of bioequivlance tests are gliclazide, norfloxacin, nimesulide, nitrendipine, nifedipine, sodium diclofenac, levosulpiride, levofloxacin, loratadine, domperidon...